PATENT CLAIM ANALYSIS

Application Number: 15742458
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "401000"]

Abstract:
Methods are provided herein for selectively killing senescent cells and for treating senescence-associated diseases and disorders by administering a senolytic agent. Senescence-associated diseases and disorders treatable by the methods using the senolytic agents described herein include cardiovascular diseases and disorders associated with or caused by arteriosclerosis, such as atherosclerosis; idiopathic pulmonary fibrosis; chronic obstructive pulmonary disease; osteoarthritis; senescence-associated ophthalmic diseases and disorders; and senescence-associated dermatological diseases and disorders. Also included herein are methods for extending lifespan.

Claim (Index 41):
The method of  claim 39 , wherein the compound is administered during two or more treatment cycles, and wherein the total dose of the compound administered during the two or more treatment cycles is an amount less than the amount effective for a cancer treatment.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 86.0
- Lexical Diversity: 1.63462
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15455684', '15827539', '15647688', '15114762', '15467129']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.884642461222366
- 35 USC 102 Novelty (BERT): 0.5754997642761107
- Combined Prediction Score: 0.8537281915277405
- Mean Citation Score: 648.2822719999998
- Max Citation Score: 688.408
- Similarity Product: 366.5283691768648

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test